Year |
Citation |
Score |
2018 |
Kosciuczuk EM, Mehrotra S, Saleiro D, Kroczynska B, Majchrzak-Kita B, Lisowski P, Driehaus C, Rogalska A, Turner A, Lienhoop T, Gius D, Fish EN, Vassilopoulos A, Platanias LC. Sirtuin 2-mediated deacetylation of cyclin-dependent kinase 9 promotes STAT1 signaling in type I interferon responses. The Journal of Biological Chemistry. PMID 30487288 DOI: 10.1074/Jbc.Ra118.005956 |
0.43 |
|
2018 |
Song HY, Rellinger EJ, Park SH, Paul P, Qiao J, Vasilopoulos A, Ozden O, Gius D, Chung DH. Inhibition of Sirtuin 6 Induces Neuroblastoma Differentiation. Anticancer Research. 38: 647-654. PMID 29374686 DOI: 10.21873/Anticanres.12268 |
0.301 |
|
2017 |
Traba J, Geiger SS, Kwarteng Siaw M, Han K, Ra OH, Siegel RM, Gius D, Sack MN. Prolonged fasting suppresses mitochondrial NLRP3 inflammasome assembly and activation via SIRT3 mediated activation of Superoxide Dismutase 2. The Journal of Biological Chemistry. PMID 28584055 DOI: 10.1074/jbc.M117.791715 |
0.351 |
|
2016 |
Vidimar V, Gius D, Chakravarti D, Bulun SE, Wei JJ, Kim JJ. Dysfunctional MnSOD leads to redox dysregulation and activation of prosurvival AKT signaling in uterine leiomyomas. Science Advances. 2: e1601132. PMID 27847869 DOI: 10.1126/Sciadv.1601132 |
0.405 |
|
2016 |
Song HY, Biancucci M, Kang HJ, O'Callaghan C, Park SH, Principe DR, Jiang H, Yan Y, Satchell KF, Raparia K, Gius D, Vassilopoulos A. SIRT2 deletion enhances KRAS-induced tumorigenesis in vivo by regulating K147 acetylation status. Oncotarget. PMID 27637077 DOI: 10.18632/oncotarget.12015 |
0.309 |
|
2016 |
Zhang H, Head PE, Daddacha W, Park SH, Li X, Pan Y, Madden MZ, Duong DM, Xie M, Yu B, Warren MD, Liu EA, Dhere VR, Li C, Pradilla I, ... ... Gius D, et al. ATRIP Deacetylation by SIRT2 Drives ATR Checkpoint Activation by Promoting Binding to RPA-ssDNA. Cell Reports. PMID 26854234 DOI: 10.1016/J.Celrep.2016.01.018 |
0.338 |
|
2015 |
Agarwal S, Zhu Y, Gius DR, Satchell KJ. Makes Caterpillars Floppy (MCFVv)-like domain of Vibrio vulnificus induces mitochondrial-mediated apoptosis. Infection and Immunity. PMID 26351282 DOI: 10.1128/IAI.00570-15 |
0.311 |
|
2015 |
Liu R, Fan M, Candas D, Qin L, Zhang X, Eldridge A, Zou JX, Zhang T, Juma S, Jin C, Li RF, Perks J, Sun LQ, Vaughan AT, Hai CX, ... Gius DR, et al. CDK1-mediated SIRT3 Activation Enhances Mitochondrial Function and Tumor Radioresistance. Molecular Cancer Therapeutics. PMID 26141949 DOI: 10.1158/1535-7163.MCT-15-0017 |
0.353 |
|
2015 |
Pillai VB, Samant S, Sundaresan NR, Raghuraman H, Kim G, Bonner MY, Arbiser JL, Walker DI, Jones DP, Gius D, Gupta MP. Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3. Nature Communications. 6: 6656. PMID 25871545 DOI: 10.1038/Ncomms7656 |
0.323 |
|
2014 |
Ozden O, Park SH, Wagner BA, Yong Song H, Zhu Y, Vassilopoulos A, Jung B, Buettner GR, Gius D. SIRT3 deacetylates and increases pyruvate dehydrogenase activity in cancer cells. Free Radical Biology & Medicine. 76: 163-72. PMID 25152236 DOI: 10.1016/J.Freeradbiomed.2014.08.001 |
0.309 |
|
2014 |
Tao R, Vassilopoulos A, Parisiadou L, Yan Y, Gius D. Regulation of MnSOD enzymatic activity by Sirt3 connects the mitochondrial acetylome signaling networks to aging and carcinogenesis. Antioxidants & Redox Signaling. 20: 1646-54. PMID 23886445 DOI: 10.1089/Ars.2013.5482 |
0.332 |
|
2013 |
Zhang H, Park SH, Pantazides BG, Karpiuk O, Warren MD, Hardy CW, Duong DM, Park SJ, Kim HS, Vassilopoulos A, Seyfried NT, Johnsen SA, Gius D, Yu DS. SIRT2 directs the replication stress response through CDK9 deacetylation. Proceedings of the National Academy of Sciences of the United States of America. 110: 13546-51. PMID 23898190 DOI: 10.1073/Pnas.1301463110 |
0.311 |
|
2013 |
Liang Q, Benavides GA, Vassilopoulos A, Gius D, Darley-Usmar V, Zhang J. Bioenergetic and autophagic control by Sirt3 in response to nutrient deprivation in mouse embryonic fibroblasts. The Biochemical Journal. 454: 249-57. PMID 23767918 DOI: 10.1042/Bj20130414 |
0.325 |
|
2012 |
Zhu Y, Park SH, Ozden O, Kim HS, Jiang H, Vassilopoulos A, Spitz DR, Gius D. Exploring the electrostatic repulsion model in the role of Sirt3 in directing MnSOD acetylation status and enzymatic activity. Free Radical Biology & Medicine. 53: 828-33. PMID 22732184 DOI: 10.1016/J.Freeradbiomed.2012.06.020 |
0.303 |
|
2010 |
Tao R, Coleman MC, Pennington JD, Ozden O, Park SH, Jiang H, Kim HS, Flynn CR, Hill S, Hayes McDonald W, Olivier AK, Spitz DR, Gius D. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Molecular Cell. 40: 893-904. PMID 21172655 DOI: 10.1016/J.Molcel.2010.12.013 |
0.35 |
|
2009 |
Kassis JN, Virador VM, Guancial EA, Kimm D, Ho AS, Mishra M, Chuang EY, Cook J, Gius D, Kohn EC. Genomic and phenotypic analysis reveals a key role for CCN1 (CYR61) in BAG3-modulated adhesion and invasion. The Journal of Pathology. 218: 495-504. PMID 19402132 DOI: 10.1002/path.2557 |
0.363 |
|
2008 |
Jacobs KM, Pennington JD, Bisht KS, Aykin-Burns N, Kim HS, Mishra M, Sun L, Nguyen P, Ahn BH, Leclerc J, Deng CX, Spitz DR, Gius D. SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression. International Journal of Biological Sciences. 4: 291-9. PMID 18781224 DOI: 10.7150/Ijbs.4.291 |
0.391 |
|
2008 |
Mishra MV, Bisht KS, Sun L, Muldoon-Jacobs K, Awwad R, Kaushal A, Nguyen P, Huang L, Pennington JD, Markovina S, Bradbury CM, Gius D. DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cells. Molecular Cancer Research : McR. 6: 243-9. PMID 18314485 DOI: 10.1158/1541-7786.Mcr-07-0373 |
0.314 |
|
2007 |
Pennington JD, Jacobs KM, Sun L, Bar-Sela G, Mishra M, Gius D. Thioredoxin and thioredoxin reductase as redox-sensitive molecular targets for cancer therapy. Current Pharmaceutical Design. 13: 3368-77. PMID 18045191 DOI: 10.2174/138161207782360528 |
0.384 |
|
2006 |
Gius D, Spitz DR. Redox signaling in cancer biology. Antioxidants & Redox Signaling. 8: 1249-52. PMID 16910772 DOI: 10.1089/Ars.2006.8.1249 |
0.343 |
|
2006 |
Nguyen P, Awwad RT, Smart DD, Spitz DR, Gius D. Thioredoxin reductase as a novel molecular target for cancer therapy. Cancer Letters. 236: 164-74. PMID 15955621 DOI: 10.1016/J.Canlet.2005.04.028 |
0.367 |
|
2005 |
Pennington JD, Wang TJ, Nguyen P, Sun L, Bisht K, Smart D, Gius D. Redox-sensitive signaling factors as a novel molecular targets for cancer therapy. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 8: 322-30. PMID 16230045 DOI: 10.1016/j.drup.2005.09.002 |
0.375 |
|
2005 |
Wang T, Hu YC, Dong S, Fan M, Tamae D, Ozeki M, Gao Q, Gius D, Li JJ. Co-activation of ERK, NF-kappaB, and GADD45beta in response to ionizing radiation. The Journal of Biological Chemistry. 280: 12593-601. PMID 15642734 DOI: 10.1074/Jbc.M410982200 |
0.448 |
|
2004 |
Smart DK, Ortiz KL, Mattson D, Bradbury CM, Bisht KS, Sieck LK, Brechbiel MW, Gius D. Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress. Cancer Research. 64: 6716-24. PMID 15374989 DOI: 10.1158/0008-5472.CAN-03-3990 |
0.449 |
|
2004 |
Cook JA, Gius D, Wink DA, Krishna MC, Russo A, Mitchell JB. Oxidative stress, redox, and the tumor microenvironment. Seminars in Radiation Oncology. 14: 259-66. PMID 15254869 DOI: 10.1016/J.Semradonc.2004.04.001 |
0.314 |
|
2004 |
Spitz DR, Azzam EI, Li JJ, Gius D. Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastasis Reviews. 23: 311-22. PMID 15197331 DOI: 10.1023/B:Canc.0000031769.14728.Bc |
0.349 |
|
2004 |
Mimnaugh EG, Xu W, Vos M, Yuan X, Isaacs JS, Bisht KS, Gius D, Neckers L. Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. Molecular Cancer Therapeutics. 3: 551-66. PMID 15141013 |
0.363 |
|
2004 |
Lagunas L, Bradbury CM, Laszlo A, Hunt CR, Gius D. Indomethacin and ibuprofen induce Hsc70 nuclear localization and activation of the heat shock response in HeLa cells. Biochemical and Biophysical Research Communications. 313: 863-70. PMID 14706622 DOI: 10.1016/j.bbrc.2003.12.018 |
0.467 |
|
2003 |
Bisht KS, Bradbury CM, Mattson D, Kaushal A, Sowers A, Markovina S, Ortiz KL, Sieck LK, Isaacs JS, Brechbiel MW, Mitchell JB, Neckers LM, Gius D. Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity. Cancer Research. 63: 8984-95. PMID 14695217 |
0.46 |
|
2003 |
Ohiro Y, Usheva A, Kobayashi S, Duffy SL, Nantz R, Gius D, Horikoshi N. Inhibition of stress-inducible kinase pathways by tumorigenic mutant p53. Molecular and Cellular Biology. 23: 322-34. PMID 12482984 |
0.323 |
|
2002 |
Karimpour S, Lou J, Lin LL, Rene LM, Lagunas L, Ma X, Karra S, Bradbury CM, Markovina S, Goswami PC, Spitz DR, Hirota K, Kalvakolanu DV, Yodoi J, Gius D. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation. Oncogene. 21: 6317-27. PMID 12214272 DOI: 10.1038/Sj.Onc.1205749 |
0.468 |
|
2002 |
Ohiro Y, Garkavtsev I, Kobayashi S, Sreekumar KR, Nantz R, Higashikubo BT, Duffy SL, Higashikubo R, Usheva A, Gius D, Kley N, Horikoshi N. A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF). Febs Letters. 524: 163-71. PMID 12135761 DOI: 10.1016/S0014-5793(02)03049-1 |
0.392 |
|
2002 |
Sekhar KR, Spitz DR, Harris S, Nguyen TT, Meredith MJ, Holt JT, Gius D, Marnett LJ, Summar ML, Freeman ML, Guis D. Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression of gamma-glutamylcysteine synthetase. Free Radical Biology & Medicine. 32: 650-62. PMID 11909699 DOI: 10.1016/S0891-5849(02)00755-4 |
0.436 |
|
2002 |
Zoberi I, Bradbury CM, Curry HA, Bisht KS, Goswami PC, Roti Roti JL, Gius D. Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines. Cancer Letters. 175: 165-73. PMID 11741744 DOI: 10.1016/S0304-3835(01)00719-4 |
0.302 |
|
Show low-probability matches. |